More positively, revenue jumped 83% to $5.8m, driven in the main by domestic sales.
Despite the deepening losses, Cann chief executive Peter Koetsier said the company was making “positive progress” in its aim to optimise production efficiencies at Mildura and “building confidence with our customers around the supply of quality medicinal cannabis products in the volume they require”.
